| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Antiphospholipid antibody syndrome | 1 | 0 | |
| Coronary artery disease | 1 | 0 | |
| Diabetes type 2 | 1 | 0 | |
| Migraine | 1 | 1 | |
| Nerve pain (neuralgia) | 1 | 3 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 4 |